Testosterone worsens the damage caused by a heart attack by increasing the number of white blood cells released from the bone marrow.

Testosterone worsens the damage caused by a heart attack by increasing the number of white blood cells released from the bone marrow. This is shown in a study by the University of Gothenburg, Sweden.

CAMBRIDGE, Mass., February 06, 2025--2seventy bio, Inc. (Nasdaq: TSVT) today provided full-year Abecma® (idecabtagene ...

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...

The new biosimilar, Celltrion’s Avtozma, was approved in both IV and subcutaneous forms to treat inflammatory conditions such as arthritis.

The FDA's approval is grounded in an evidence totality and comprehensive data package, which includes outcomes from a study.

NYU Langone Health in New York City reportedly cancelled the appointments of two transgender children scheduled to receive ...

A recent study found that combined tocilizumab and glucocorticoid therapy for at least 6 months did not fully eliminate ...

The US Food and Drug Administration (FDA) has approved Avtozma (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and ...

The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as ...

January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...